Prevalence of barrett's esophagus in caucasian women not selected for gerd

Thomas McGinn, Stephen J. Lanspa

Research output: Contribution to journalArticle

Abstract

It has been suggested that screening for Barren's esophagus be directed to high risk groups (Gastrointest Endosc 1988: 34: 18S). In patients with GERD referred for endoscopy, the prevalence of Barrett's esophagus is reported to be 10-30%, with men outnumbering women 3:1. Due to referral bias, these figures do not represent population prevalence. The prevalence of Barrett's esophagus in women is unknown and difficult to estimate. Our aim was to determine the prevalence of Barrett's esophagus in female subjects who had not sought attention for gastrointestinal symptoms. Methods: Caucasian females were referred for endoscopic biopsy of the duodenum as part of an osteoporosis research protocol. Subjects had not sought a gastrointestinal evaluation for symptoms. Esophagogastroduodenoscopy was performed, and Barrett's esophagus was specifically sought with biopsies of the esophagogastric junction if abnormal. Barrett's esophagus was defined as columnar epithelium extending >3 cm. into the tubular esophagus or when specialized columnar epithelium was found on esophageal biopsy. Results: 182 subjects (age 45 +/-17 years) were studied. Two women, age 35 and 56, had Barrett's esophagus yielding a prevalence of 1.1%. The length of Barrett's epithelium was 2 cm and 5 cm, respectively. Both had specialized columnar mucosa on biopsy. An abnormal gastroesophageal junction was noted in 6 subjects; however, only two were found to have specialized columnar epithelium. Conclusion: In unselected female Caucasians, the prevalence of Barrett's esophagus is not rare (prevalence 1.1%). Gender should not be used as a criterion when deciding which patients with GERD should be screened for Barrett's esophagus.

Original languageEnglish
JournalGastrointestinal Endoscopy
Volume45
Issue number4
StatePublished - 1997

Fingerprint

Barrett Esophagus
Biopsy
Esophagogastric Junction
Epithelium
Gastroesophageal Reflux
Esophagus
Digestive System Endoscopy
Symptom Assessment
Duodenum
Endoscopy
Osteoporosis
Mucous Membrane
Referral and Consultation

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

Prevalence of barrett's esophagus in caucasian women not selected for gerd. / McGinn, Thomas; Lanspa, Stephen J.

In: Gastrointestinal Endoscopy, Vol. 45, No. 4, 1997.

Research output: Contribution to journalArticle

@article{d9d43841033c4006bafc035aa7d15609,
title = "Prevalence of barrett's esophagus in caucasian women not selected for gerd",
abstract = "It has been suggested that screening for Barren's esophagus be directed to high risk groups (Gastrointest Endosc 1988: 34: 18S). In patients with GERD referred for endoscopy, the prevalence of Barrett's esophagus is reported to be 10-30{\%}, with men outnumbering women 3:1. Due to referral bias, these figures do not represent population prevalence. The prevalence of Barrett's esophagus in women is unknown and difficult to estimate. Our aim was to determine the prevalence of Barrett's esophagus in female subjects who had not sought attention for gastrointestinal symptoms. Methods: Caucasian females were referred for endoscopic biopsy of the duodenum as part of an osteoporosis research protocol. Subjects had not sought a gastrointestinal evaluation for symptoms. Esophagogastroduodenoscopy was performed, and Barrett's esophagus was specifically sought with biopsies of the esophagogastric junction if abnormal. Barrett's esophagus was defined as columnar epithelium extending >3 cm. into the tubular esophagus or when specialized columnar epithelium was found on esophageal biopsy. Results: 182 subjects (age 45 +/-17 years) were studied. Two women, age 35 and 56, had Barrett's esophagus yielding a prevalence of 1.1{\%}. The length of Barrett's epithelium was 2 cm and 5 cm, respectively. Both had specialized columnar mucosa on biopsy. An abnormal gastroesophageal junction was noted in 6 subjects; however, only two were found to have specialized columnar epithelium. Conclusion: In unselected female Caucasians, the prevalence of Barrett's esophagus is not rare (prevalence 1.1{\%}). Gender should not be used as a criterion when deciding which patients with GERD should be screened for Barrett's esophagus.",
author = "Thomas McGinn and Lanspa, {Stephen J.}",
year = "1997",
language = "English",
volume = "45",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Prevalence of barrett's esophagus in caucasian women not selected for gerd

AU - McGinn, Thomas

AU - Lanspa, Stephen J.

PY - 1997

Y1 - 1997

N2 - It has been suggested that screening for Barren's esophagus be directed to high risk groups (Gastrointest Endosc 1988: 34: 18S). In patients with GERD referred for endoscopy, the prevalence of Barrett's esophagus is reported to be 10-30%, with men outnumbering women 3:1. Due to referral bias, these figures do not represent population prevalence. The prevalence of Barrett's esophagus in women is unknown and difficult to estimate. Our aim was to determine the prevalence of Barrett's esophagus in female subjects who had not sought attention for gastrointestinal symptoms. Methods: Caucasian females were referred for endoscopic biopsy of the duodenum as part of an osteoporosis research protocol. Subjects had not sought a gastrointestinal evaluation for symptoms. Esophagogastroduodenoscopy was performed, and Barrett's esophagus was specifically sought with biopsies of the esophagogastric junction if abnormal. Barrett's esophagus was defined as columnar epithelium extending >3 cm. into the tubular esophagus or when specialized columnar epithelium was found on esophageal biopsy. Results: 182 subjects (age 45 +/-17 years) were studied. Two women, age 35 and 56, had Barrett's esophagus yielding a prevalence of 1.1%. The length of Barrett's epithelium was 2 cm and 5 cm, respectively. Both had specialized columnar mucosa on biopsy. An abnormal gastroesophageal junction was noted in 6 subjects; however, only two were found to have specialized columnar epithelium. Conclusion: In unselected female Caucasians, the prevalence of Barrett's esophagus is not rare (prevalence 1.1%). Gender should not be used as a criterion when deciding which patients with GERD should be screened for Barrett's esophagus.

AB - It has been suggested that screening for Barren's esophagus be directed to high risk groups (Gastrointest Endosc 1988: 34: 18S). In patients with GERD referred for endoscopy, the prevalence of Barrett's esophagus is reported to be 10-30%, with men outnumbering women 3:1. Due to referral bias, these figures do not represent population prevalence. The prevalence of Barrett's esophagus in women is unknown and difficult to estimate. Our aim was to determine the prevalence of Barrett's esophagus in female subjects who had not sought attention for gastrointestinal symptoms. Methods: Caucasian females were referred for endoscopic biopsy of the duodenum as part of an osteoporosis research protocol. Subjects had not sought a gastrointestinal evaluation for symptoms. Esophagogastroduodenoscopy was performed, and Barrett's esophagus was specifically sought with biopsies of the esophagogastric junction if abnormal. Barrett's esophagus was defined as columnar epithelium extending >3 cm. into the tubular esophagus or when specialized columnar epithelium was found on esophageal biopsy. Results: 182 subjects (age 45 +/-17 years) were studied. Two women, age 35 and 56, had Barrett's esophagus yielding a prevalence of 1.1%. The length of Barrett's epithelium was 2 cm and 5 cm, respectively. Both had specialized columnar mucosa on biopsy. An abnormal gastroesophageal junction was noted in 6 subjects; however, only two were found to have specialized columnar epithelium. Conclusion: In unselected female Caucasians, the prevalence of Barrett's esophagus is not rare (prevalence 1.1%). Gender should not be used as a criterion when deciding which patients with GERD should be screened for Barrett's esophagus.

UR - http://www.scopus.com/inward/record.url?scp=33748975158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748975158&partnerID=8YFLogxK

M3 - Article

VL - 45

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 4

ER -